A Case Suspected for Yellow Fever Vaccine‐Associated Viscerotropic Disease in the Netherlands. Issue 6 (11th June 2014)

• Record Type: Journal Article
• Authors: van de Pol, Eva M.; Gisolf, Elizabeth H.; Richter, Clemens
• Is Part Of: Journal of travel medicine. Volume 21:Issue 6(2014)
• Page Start: 421
• Page End: 424
• Publication Date: 2014-06-11
• Subjects: Communicable diseases -- Prevention -- Periodicals; Medicine, Preventive -- Periodicals; Travel -- Periodicals; 613.6805
• DOI: 10.1111/jtm.12135
• Languages: English
• ISSNs: 1195-1982

Abstract

<abstract abstract-type="main" id="jtm12135-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p id="jtm12135-para-0001">Yellow fever (YF) 17D vaccine is one of the most successful vaccines ever developed. Since 2001, 56 cases of yellow fever vaccine‐associated viscerotropic disease (YEL‐AVD) have been published in the peer‐reviewed literature. Here, we report a new case suspected for YEL‐AVD in the Netherlands. Further research is needed to determine the true incidence of YEL‐AVD and to clarify host and vaccine‐associated factors in the pathogenesis of YEL‐AVD. Because of the potential adverse events, healthcare providers should carefully consider vaccination only in people who are truly at risk for YF infection, especially in primary vaccine recipients.</p> </abstract>